Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 1999

View Archived Issues

Fluvastatin induces delayed improvement in coronary flow reserve

BioNumerik initiates phase I clinical trials of promising new anticancer compound

Targeted Genetics: Q4 1998 highlights

AxyS Pharmaceuticals: Q4 1998 highlights

rsIL-4R as a potential treatment for atopic eczema

Transcutaneous nitroglycerin evaluated in controlled trial for MED

Anesta begins launch of novel analgesic

Agents for stimulating upper and lower GI motility in development at Labs. Jacques Logeais

Licensing opportunity from Yeda: vitamin D3 analogue with multiple potential indications

Esteve patents novel compounds with multiple effects on the CNS

New radiolabeled cocaine analogues for diagnostic imaging designed at Emory University

TASP-V, a novel and selective NPY Y2 agonist for rhinitis and asthma

Optically pure trimebutine metabolite useful for chronic pain

Kaneka presents new HSF inhibitors

APA Assay accurately diagnoses patients with fibromyalgia

Rhone-Poulenc Rorer claims series for diabetes and diabetic complications

Angelini studies effects of structural modifications to trazodone on binding profile

AN-207, a targeted cytotoxic compound with potential in treating prostate cancer

TNF-alpha inhibitor discovered at Nisshin Flour Milling as new lead antiinflammatory compound

Microbially produced 5alpha-reductase inhibitor discovered at Snow Brand

Variagenics, Nova Molecular team up to study treatments for neurological diseases

Novel hemostatic cofactors available for licensing from OMRF

New patent strengthens Millennium's position on UCPH

Avanir submits additional efficacy data for docosanol cream to FDA

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

Interim safety results for Flocor in sickle cell patients with acute chest syndrome

OraVax and Peptide Therapeutics merger to be completed early in second quarter

Sustiva recommended for full marketing approval in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...